Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

L. Sacco, Ralph; Diener, Hans‐Christoph; Yusuf, Salim; Cotton, Daniel; Ôunpuu, Stephanie; A Lawton, William; Palesch, Yuko; H. Martin, Renée; W. Albers, Gregory; M. Bath, Philip; M. Bornstein, Natan; P.L. Chan, Bernard; Chen, Sien-Tsong; Cunha, Luı́s; Dahlöf, Björn; De Keyser, Jacques; A. Donnan, Geoffrey; J. Estol, Conrado; B. Gorelick, Philip; Gu, Vivian; Hermansson, Karin; Hilbrich, Lutz; Kaste, Markku; Lü, Chuanzhen; Machnig, Thomas; Pais, Prem; Roberts, Robin; Skvortsova, Veronika; Teal, Philip; Toni, Danilo; P. VanderMaelen, Cam; Voigt, Thor; A. Weber, Michael; Yoon, Byung‐Woo

doi:10.1056/nejmoa0805002

Public

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

Published in New England Journal of Medicine • Aug 27, 2008

Authors:

Ralph L. Sacco

Hans‐Christoph Diener

Salim Yusuf

Abstract

BACKGROUND: Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens--aspirin plus extended-release dipyridamole (ASA-ERDP) versus clopidogrel. METHODS: In this double-blind, 2-by-2 factorial trial, we randomly as...

Subject

Dipyridamole

Clopidogrel

Aspirin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!